Precursors of cognitive impairments in psychotic disorders: A population-based study

Psychiatry Research

Volumn 210, Issue 1, 2013, Pages 329-337

  Müller, Mario ^a,b   Vetter, Stefan ^a,b   Weiser, Mark ^c   Frey, Franz ^d   Ajdacic Gross, Vladeta ^b   Stieglitz, Rolf Dieter ^e   Rössler, Wulf ^b,f  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b UNIVERSITY HOSPITAL OF PSYCHIATRY   (Switzerland)

^c SHEBA MEDICAL CENTER   (Israel)

^d Medical Services of the Swiss Armed Forces   (Switzerland)

^e UNIVERSITY HOSPITAL BASEL   (Switzerland)

^f Swiss Federal Institute of Technology Collegium Helveticum   (Switzerland)

Author keywords

Cognitive deficits; Markers of premorbid cognitive impairments; Mental disorders; Psychosis; Verbal and performance IQ

Indexed keywords

ADULT; ANXIETY DISORDER; ARMY; ARTICLE; COGNITIVE DEFECT; COHORT ANALYSIS; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DEPRESSION; DISEASE ASSOCIATION; DYSLEXIA; HUMAN; ICD-10; INTELLECTUAL IMPAIRMENT; INTELLIGENCE QUOTIENT; MALE; MENTAL PERFORMANCE; NEUROPSYCHOLOGICAL TEST; NEUROPSYCHOLOGY; OBSESSIVE COMPULSIVE DISORDER; PERSONALITY DISORDER; POPULATION RESEARCH; PRIORITY JOURNAL; PSYCHOSIS; RISK FACTOR; SCORING SYSTEM;

COGNITIVE DEFICITS; MARKERS OF PREMORBID COGNITIVE IMPAIRMENTS; MENTAL DISORDERS; PSYCHOSIS; VERBAL AND PERFORMANCE IQ;

ADOLESCENT; COGNITION DISORDERS; COMMUNITY HEALTH PLANNING; HUMANS; INTELLIGENCE TESTS; LOGISTIC MODELS; MALE; MILITARY PERSONNEL; NEUROPSYCHOLOGICAL TESTS; PERSONALITY DISORDERS; PSYCHOTIC DISORDERS; RETROSPECTIVE STUDIES; STATISTICS, NONPARAMETRIC; YOUNG ADULT;

EID: 84885851295     PISSN: 01651781     EISSN: 18727123     Source Type: Journal    
DOI: 10.1016/j.psychres.2013.05.035     Document Type: Article

References (67)

1. Althoff K., Jäger A.O. Der WILDE-Intelligenz-Test-Ein Strukturdiagnostikum 1983, Hogrefe, Göttingen.
2. Amminger G.P., Edwards J., Brewer W.J., Harrigan S., McGorry P.D. Duration of untreated psychosis and cognitive deterioration in first-episode schizophrenia. Schizophrenia Research 2002, 54(3):223-230.
3. Amminger G.P., Schlogelhofer M., Lehner T., Looser Ott S., Friedrich M.H., Aschauer H.N. Premorbid performance IQ deficit in schizophrenia. Acta Psychiatrica Scandinavica 2000, 102(6):414-422.
4. Aoyama N., Theberge J., Drost D.J., Manchanda R., Northcott S., Neufeld R.W., Menon R.S., Rajakumar N., Pavlosky W.F., Densmore M., Schaefer B., Williamson P.C. Grey matter and social functioning correlates of glutamatergic metabolite loss in schizophrenia. British Journal of Psychiatry 2011, 198(6):448-456.
5. Aylward E., Walker E., Bettes B. Intelligence in schizophrenia: meta-analysis of the research. Schizophrenia Bulletin 1984, 10(3):430-459.
6. Bechard-Evans L., Iyer S., Lepage M., Joober R., Malla A. Investigating cognitive deficits and symptomatology across pre-morbid adjustment patterns in first-episode psychosis. Psychological Medicine 2010, 40(5):749-759.
7. Bedwell J.S., Keller B., Smith A.K., Hamburger S., Kumra S., Rapoport J.L. Why does postpsychotic IQ decline in childhood-onset schizophrenia?. American Journal of Psychiatry 1999, 156(12):1996-1997.
8. Bora E., Yucel M., Pantelis C. Cognitive functioning in schizophrenia, schizoaffective disorder and affective psychoses: meta-analytic study. British Journal of Psychiatry 2009, 195(6):475-482.
9. Cannon M., Caspi A., Moffitt T.E., Harrington H., Taylor A., Murray R.M., Poulton R. Evidence for early-childhood, pan-developmental impairment specific to schizophreniform disorder: results from a longitudinal birth cohort. Archives of General Psychiatry 2002, 59(5):449-456.
10. Clarke M.C., Tanskanen A., Huttunen M., Leon D.A., Murray R.M., Jones P.B., Cannon M. Increased risk of schizophrenia from additive interaction between infant motor developmental delay and obstetric complications: evidence from a population-based longitudinal study. American Journal of Psychiatry 2011, 168(12):1295-1302.
11. Ekstrom R., French J.W., Harman H.H. Manual for KIT of Factor-referenced Cognitive Tests 1976, Educational Testing Service, Princton, NJ.
12. Foppa, N., Roduner, K., Oberwiler, A., 1997. Die Konstruktvalidität des Test 95. Abteilung Angewandte Psychologie der Universität, Zur̈rich.
13. Goldberg T.E., Ragland J.D., Torrey E.F., Gold J.M., Bigelow L.B., Weinberger D.R. Neuropsychological assessment of monozygotic twins discordant for schizophrenia. Archives of General Psychiatry 1990, 47(11):1066-1072.
14. Goldstein J.M., Seidman L.J., Buka S.L., Horton N.J., Donatelli J.L., Rieder R.O., Tsuang M.T. Impact of genetic vulnerability and hypoxia on overall intelligence by age 7 in offspring at high risk for schizophrenia compared with affective psychoses. Schizophrenia Bulletin 2000, 26(2):323-334.
15. Goulding S.M., Chien V.H., Compton M.T. Prevalence and correlates of school drop-out prior to initial treatment of nonaffective psychosis: further evidence suggesting a need for supported education. Schizophrenia Research 2010, 116(2-3):228-233.
16. Gunnell D., Harrison G., Rasmussen F., Fouskakis D., Tynelius P. Associations between premorbid intellectual performance, early-life exposures and early-onset schizophrenia. Cohort study. British Journal of Psychiatry 2002, 181:298-305.
17. Hans S.L., Auerbach J.G., Auerbach A.G., Marcus J. Development from birth to adolescence of children at-risk for schizophrenia. Journal of Child and Adolescent Psychopharmacology 2005, 15(3):384-394.
18. Harvey P.D. When does cognitive decline occur in the period prior to the first episode of schizophrenia?. Psychiatry (Edgmont) 2009, 6(7):12-14.
19. Heinrichs R.W., Zakzanis K.K. Neurocognitive deficit in schizophrenia: a quantitative review of the evidence. Neuropsychology 1998, 12(3):426-445.
20. Howard R., Almeida O., Levy R. Phenomenology, demography and diagnosis in late paraphrenia. Psychological Medicine 1994, 24(2):397-410.
21. Huber R. Test 95. Von der Planung bis zur Einfur̈hrung eines Kurzintelligenztests 1999, Lang, Bern.
22. Hughes C., Kumari V., Soni W., Das M., Binneman B., Drozd S., O'Neil S., Mathew V., Sharma T. Longitudinal study of symptoms and cognitive function in chronic schizophrenia. Schizophrenia Research 2003, 59(2-3):137-146.
23. Isohanni M., Isohanni I., Koponen H., Koskinen J., Laine P., Lauronen E., Miettunen J., Maki P., Riala K., Rasanen S., Saari K., Tienari P., Veijola J., Murray G. Developmental precursors of psychosis. Current Psychiatry Reports 2004, 6(3):168-175.
24. Jäger A.O. Mehrmodale Klassifikation von Intelligenzleistungen: Experimentell kontrollierte Weiterentwicklung eines deskriptiven Intelligenzstrukturmodells. Diagnostica 1982, 28(3):195-225.
25. Jones P., Rodgers B., Murray R., Marmot M. Child development risk factors for adult schizophrenia in the British 1946 birth cohort. Lancet 1994, 344(8934):1398-1402.
26. Jundong J., Kuja-Halkola R., Hultman C., Langstrom N., D'Onofrio B.M., Lichtenstein P. Poor school performance in offspring of patients with schizophrenia: what are the mechanisms?. Psychological Medicine 2012, 42(1):111-123.
27. Keefe R.S., Fenton W.S. How should DSM-V criteria for schizophrenia include cognitive impairment?. Schizophrenia Bulletin 2007, 33(4):912-920.
28. Kelly D.L., Buchanan R.W., Boggs D.L., McMahon R.P., Dickinson D., Nelson M., Gold J.M., Ball M.P., Feldman S., Liu F., Conley R.R. A randomized double-blind trial of atomoxetine for cognitive impairments in 32 people with schizophrenia. Journal of Clinical Psychiatry 2009, 70(4):518-525.
29. Khandaker G.M., Barnett J.H., White I.R., Jones P.B. A quantitative meta-analysis of population-based studies of premorbid intelligence and schizophrenia. Schizophrenia Research 2011, 132(2-3):220-227.
30. Korkeila J., Salokangas R.K., Heinimaaa M., Svirskis T., Laine T., Ruhrmann S., von Reventlow H., Juckel G., Linszen D., Birchwood M., Klosterkotter J. Physical illnesses, developmental risk factors and psychiatric diagnoses among subjects at risk of psychosis. European Psychiatry 2013, 28(3):135-140.
31. Kremen W.S., Vinogradov S., Poole J.H., Schaefer C.A., Deicken R.F., Factor-Litvak P., Brown A.S. Cognitive decline in schizophrenia from childhood to midlife: a 33-year longitudinal birth cohort study. Schizophrenia Research 2010, 118(1-3):1-5.
32. Lappin J.M., Morgan K.D., Morgan C., Dazzan P., Reichenberg A., Zanelli J.W., Fearon P., Jones P.B., Lloyd T., Tarrant J., Farrant A., Leff J., Murray R.M. Duration of untreated psychosis and neuropsychological function in first episode psychosis. Schizophrenia Research 2007, 95(1-3):103-110.
33. Manzano J., Zabala I., Borella E., Favre C., Fischer W., Gex M., Laufer D., Seidl R., Urban D. Continuity and discontinuity of psychopathology: a study of patients examined as children and as adults. I. Antecedents of adult schizophrenic disorders. Schweizer Archiv fur Neurologie und Psychiatrie 1992, 143(1):5-25.
34. Matheson S.L., Shepherd A.M., Laurens K.R., Carr V.J. A systematic meta-review grading the evidence for non-genetic risk factors and putative antecedents of schizophrenia. Schizophrenia Research 2011, 133(1-3):133-142.
35. Maydell R.J., van der Walt C., Roos J.L., Scribante L., Ladikos A. Clinical characteristics and premorbid variables in childhood-onset schizophrenia: a descriptive study of twelve cases from a schizophrenia founder population. African Journal of Psychiatry (Johannesburg) 2009, 12(2):144-148.
36. McDonald C., Murphy K.C. The new genetics of schizophrenia. Psychiatric Clinics of North America 2003, 26(1):41-63.
37. Mechelli A., Riecher-Rossler A., Meisenzahl E.M., Tognin S., Wood S.J., Borgwardt S.J., Koutsouleris N., Yung A.R., Stone J.M., Phillips L.J., McGorry P.D., Valli I., Velakoulis D., Woolley J., Pantelis C., McGuire P. Neuroanatomical abnormalities that predate the onset of psychosis: a multicenter study. Archives of General Psychiatry 2011, 68(5):489-495.
38. Moreno D., Moreno-Iniguez M., Vigil D., Castro-Fornieles J., Ortuno F., Gonzalez-Pinto A., Parellada M., Baeza I., Otero S., Graell M., Aldama A., Arango C. Obstetric complications as a risk factor for first psychotic episodes in childhood and adolescence. European Child and Adolescent Psychiatry 2009, 18(3):180-184.
39. Mrad A., Mechri A., Slama H., Mokni S., Letaief M., Gha L. Correlations between obstetric complications and neurological soft signs in Tunisian patients with schizophrenia. Psychiatry and Clinical Neurosciences 2010, 64(6):645-648.
40. Müller M., Riecher A., Kammermann J., Stieglitz R.D., Stettbacher A., Vetter S. Prediction of caseness for mental pathology in Swiss conscripts: the self-screen prodrome. Military Medicine 2009, 174(12):1270-1275.
41. Müller, M., Kowalewski, R., Metzler, S., Stettbacher, A., Rössler, W., Vetter, S., Associations between IQ and alcohol consumption in a population of young males: a large database analysis. Social Psychiatry and Psychiatric Epidemiology, in press.
42. Müller U., Werheid K., Hammerstein E., Jungmann S., Becker T. Prefrontal cognitive deficits in patients with schizophrenia treated with atypical or conventional antipsychotics. European Psychiatry 2005, 20(1):70-73.
43. Murray R.M., Lewis S.W. Is schizophrenia a neurodevelopmental disorder?. British Medical Journal (Clinical Research Edition) 1987, 295(6600):681-682.
44. Niemi L.T., Suvisaari J.M., Tuulio-Henriksson A., Lonnqvist J.K. Childhood developmental abnormalities in schizophrenia: evidence from high-risk studies. Schizophrenia Research 2003, 60(2-3):239-258.
45. O'Connor J.A., Wiffen B.D., Reichenberg A., Aas M., Falcone M.A., Russo M., Sood P.G., Taylor H., David A.S. Is deterioration of IQ a feature of first episode psychosis and how can we measure it?. Schizophrenia Research 2012, 137(1-3):104-109.
46. Ojeda N., Sanchez P., Pena J., Elizagarate E., Yoller A.B., Larumbe J., Gutierrez M., Casais L., Ezcurra J. Verbal fluency in schizophrenia: does cognitive performance reflect the same underlying mechanisms in patients and healthy controls?. Journal of Nervous and Mental Disease 2010, 198(4):286-291.
47. Ott S.L., Spinelli S., Rock D., Roberts S., Amminger G.P., Erlenmeyer-Kimling L. The New York high-risk project: social and general intelligence in children at risk for schizophrenia. Schizophrenia Research 1998, 31(1):1-11.
48. Owen M.J., O'Donovan M.C., Thapar A., Craddock N. Neurodevelopmental hypothesis of schizophrenia. British Journal of Psychiatry 2011, 198(3):173-175.
49. Purcell D.W., Lewine R.R., Caudle J., Price L.R. Sex differences in verbal IQ-performance IQ discrepancies among patients with schizophrenia and normal volunteers. Journal of Abnormal Psychology 1998, 107(1):161-165.
50. Quraishi S., Frangou S. Neuropsychology of bipolar disorder: a review. Journal of Affective Disorders 2002, 72(3):209-226.
51. Rabinowitz J., Reichenberg A., Weiser M., Mark M., Kaplan Z., Davidson M. Cognitive and behavioural functioning in men with schizophrenia both before and shortly after first admission to hospital. Cross-sectional analysis. British Journal of Psychiatry 2000, 177:26-32.
52. Rajji T.K., Ismail Z., Mulsant B.H. Age at onset and cognition in schizophrenia: meta-analysis. British Journal of Psychiatry 2009, 195(4):286-293.
53. Reichenberg A. Cognitive impairment as a risk factor for psychosis. Dialogues Clin Neurosci 2005, 7(1):31-38.
54. Reichenberg A., Rabinowitz J., Weiser M., Mark M., Kaplan Z., Davidson M. Premorbid functioning in a national population of male twins discordant for psychoses. American Journal of Psychiatry 2000, 157(9):1514-1516.
55. Reichenberg A., Weiser M., Caspi A., Knobler H.Y., Lubin G., Harvey P.D., Rabinowitz J., Davidson M. Premorbid intellectual functioning and risk of schizophrenia and spectrum disorders. Journal of Clinical and Experimental Neuropsychology 2006, 28(2):193-207.
56. Remillard S., Pourcher E., Cohen H. Long-term effects of risperidone versus haloperidol on verbal memory, attention, and symptomatology in schizophrenia. Journal of the International Neuropsychological Society 2008, 14(1):110-118.
57. Ross R.G., Wagner B., Heinlein S., Zerbe G.O. The stability of inhibitory and working memory deficits in children and adolescents who are children of parents with schizophrenia. Schizophrenia Bulletin 2008, 34(1):47-51.
58. Rund B.R. A review of longitudinal studies of cognitive functions in schizophrenia patients. Schizophrenia Bulletin 1998, 24(3):425-435.
59. Selva-Vera G., Balanza-Martinez V., Salazar-Fraile J., Sanchez-Moreno J., Martinez-Aran A., Correa P., Vieta E., Tabares-Seisdedos R. The switch from conventional to atypical antipsychotic treatment should not be based exclusively on the presence of cognitive deficits. A pilot study in individuals with schizophrenia. BMC Psychiatry 2010, 10:47.
60. Shim J.C., Jung D.U., Jung S.S., Seo Y.S., Cho D.M., Lee J.H., Lee S.W., Kong B.G., Kang J.W., Oh M.K., Kim S.D., McMahon R.P., Kelly D.L. Adjunctive varenicline treatment with antipsychotic medications for cognitive impairments in people with schizophrenia: a randomized double-blind placebo-controlled trial. Neuropsychopharmacology 2012, 37(3):660-668.
61. Silverstein M.L., Mavrolefteros G., Close D. Premorbid adjustment and neuropsychological performance in schizophrenia. Schizophrenia Bulletin 2002, 28(1):157-165.
62. Sobin C., Blundell M.L., Conry A., Weiller F., Gavigan C., Haiman C., Karayiorgou M. Early, non-psychotic deviant behavior in schizophrenia: a possible endophenotypic marker for genetic studies. Psychiatry Research 2001, 101(2):101-113.
63. StataCorp Stata Statistical Software (Version Release 10) 2007, StataCorp, College Station, TX.
64. Stilo S.A., Murray R.M. The epidemiology of schizophrenia: replacing dogma with knowledge. Dialogues in Clinical Neuroscience 2010, 12(3):305-315.
65. van Winkel R., Myin-Germeys I., Delespaul P., Peuskens J., De Hert M., van Os J. Premorbid IQ as a predictor for the course of IQ in first onset patients with schizophrenia: a 10-year follow-up study. Schizophrenia Research 2006, 88(1-3):47-54.
66. Weinberger D.R. Implications of normal brain development for the pathogenesis of schizophrenia. Archives of General Psychiatry 1987, 44(7):660-669.
67. WHO International Statistical Classification of Diseases and Health Related Problems 2004, World Health Organization, Geneva.